Creating a network for precision oncology in central-southern Italy
Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)
This study is trying to create a network of labs in central-southern Italy to better understand cancer by improving testing methods and sharing information about tumors to help personalize treatment for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 16000 (estimated) |
| Sex | All |
| Sponsor | National Cancer Institute, Naples Academic / other |
| Locations | 1 site (Naples) |
| Trial ID | NCT06894823 on ClinicalTrials.gov |
What this trial studies
COESIT aims to establish a network of reference laboratories in central-southern Italy to enhance the genetic and molecular characterization of tumors. The initiative involves upgrading laboratory technologies, standardizing sequencing procedures, and creating a shared database that integrates sequencing data with clinicopathological information. This collaborative effort will facilitate research into genetic alterations in tumors and help identify biomarkers for precision and personalized oncology. The study will collect both retrospective and prospective data from cancer patients in the region.
Who should consider this trial
Good fit: Ideal candidates for this study are cancer patients residing in the central-southern regions of Italy.
Not a fit: Patients outside the central-southern regions of Italy or those without a cancer diagnosis may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly improve the implementation of personalized cancer treatments based on genetic profiling.
How similar studies have performed: Other studies focusing on precision oncology and genomic profiling have shown promise, indicating that this approach could be beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cancer patients * Patients from the central-southern regions Exclusion Criteria: \-
Where this trial is running
Naples
- Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale — Naples, Italy (Recruiting)
Study contacts
- Principal investigator: Antonella De Luca — Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale
- Study coordinator: Antonella De Luca
- Email: a.deluca@istitutotumori.na.it
- Phone: 08117770603
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.